Final Analysis Of Safety And Exploratory Echo Data In A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study To Evaluate JK07 In Subjects With Heart Failure With Reduced Ejection Fraction
W.H. Wilson Tang(Cleveland Clinic), Samuel L. Murphy(Integrated BioTherapeutics (United States)), Aferdita Spahillari(Massachusetts General Hospital), Matthew T. Wheeler(Stanford University), Mahwash Kassi(Houston Methodist), Shalabh Singhal(Integrated BioTherapeutics (United States)), Nancy K. Sweitzer(National Heart Lung and Blood Institute), Johannes Steiner(University of Portland), Amanda McEwen, Neal W. Salomon, Justin L. Grodin(The University of Texas Southwestern Medical Center)
Cited by 4
Related Papers
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Gut Microbiota in Cardiovascular Health and Disease
|Circulation Research|2017|1.6k